Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy

These data indicate that MGMT methylation is prognostically significant in glioblastomas given chemoradiotherapy in the routine clinic; furthermore, the extent of methylation may be used to provide additional prognostic stratification.